Chikungunya Clinical Trials

Find Chikungunya Clinical Trials Near You

Real-world Effectiveness, Safety, and Immunogenicity of Chikungunya Vaccination During an Epidemic Period: an Ambispective Study in Réunion Island and French Guiana.

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

In the context of the ongoing chikungunya epidemic in Réunion Island and the anticipated epidemic in French Guiana, the investigators propose an ambispective study to evaluate the real-world effectiveness, safety, and immunogenicity of the recommended vaccines, IXCHIQ® and VIMKUNYA®, as defined by the French National Authority for Health (HAS).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Retrospective study VIMKUNYA or IXCHIQ

• Adult (Aged 18 or above)

• Adult (Aged 18 or above) eligible for anti-chikungunya vaccination according to French High Health Authority (HAS)

⁃ Prospective study

• VIMKUNYA: Adult (Aged 18 or above) eligible for anti-chikungunya vaccination according to French High Health Authority (HAS)

• IXCHIQ: Adult (Aged 18 -64) eligible for anti-chikungunya vaccination according to French High Health Authority (HAS) Eligibility Criteria common to both groups

• Agreeing to participate in study

• Beneficiary of French social security coverage

• Signature of informed consent form

Locations
Other Locations
French Guiana
Centre Hospitalier Universitaire de Guyane
RECRUITING
Cayenne
Contact Information
Primary
Patrick GERARDIN, MD
patrick.gerardin@chu-reunion.fr
(262) 2 62 35 9435
Backup
Florence LEFEBVRE D'HELLENCOURT
promotion.drci@chu-reunion.fr
+262 262 75 34 71
Time Frame
Start Date: 2025-04-18
Estimated Completion Date: 2027-12
Participants
Target number of participants: 1505
Treatments
Experimental: Vaccinated group
Patients who will be vaccinated with the IXCHIQ vaccine or the VIMKUNYA vaccine
No_intervention: Non-vaccinated group
Patient who will not be vaccinated
Related Therapeutic Areas
Sponsors
Collaborators: Bavarian Nordic, ANRS, Emerging Infectious Diseases, Région Réunion, ARS La Réunion, Valneva Austria GmbH, Agence Régionale de Santé Guyane, Direction Générale de l'Offre de Soins
Leads: Centre Hospitalier Universitaire de la Réunion

This content was sourced from clinicaltrials.gov